Becton, Dickinson & Co. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Becton, Dickinson & Co. on January 25, 2007. The filing serves to disclose the company's results of operations and financial condition, referencing a press release dated January 25, 2007 (Exhibit 99.1). The report focuses on the methodology for presenting non-GAAP financial measures for the first quarter of fiscal year 2007 and comparative periods in fiscal year 2006.
Key Financial Metrics and Methodology
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it details the adjustments management applies to GAAP figures to present non-GAAP measures:
- Revenues: Growth rates are presented at constant foreign exchange rates to remove currency fluctuation impacts.
- Selling and Administrative Expense: Adjusted to exclude insurance settlements that lowered reported expenses in prior periods.
- Research and Development (R&D) Expense: Adjusted to exclude in-process R&D charges related to the acquisition of TriPath Imaging, Inc. (Q1 2007) and GeneOhm Sciences Inc. (Q2 2006 and full year 2006).
- Operating Income and Income from Continuing Operations: Adjusted to exclude the aforementioned insurance settlements and in-process R&D charges.
- Income Taxes: Adjusted to exclude the impact of insurance settlements.
- Earnings Per Share (EPS): Adjusted to exclude the TriPath in-process R&D charge for Q1 2007 and insurance settlements/GeneOhm charges for 2006 periods.
Material Changes and Unusual Items
The filing identifies specific non-recurring items that materially affected reported GAAP results in the periods discussed:
- TriPath Imaging Acquisition: An in-process R&D charge impacted Q1 2007 results, lowering reported R&D expense, operating income, and EPS.
- GeneOhm Sciences Acquisition: An in-process R&D charge impacted Q2 2006 and full-year 2006 results.
- Insurance Settlements: Settlements occurring in 2006 reduced reported selling and administrative expenses but increased reported income tax expense and effective tax rates.
Management Commentary and Outlook
Management states that these non-GAAP measures are used internally for performance evaluation and budget planning. They believe these adjusted figures better reflect underlying operational performance and facilitate period-to-period comparisons by excluding items not considered part of ordinary operations. Management cautions that non-GAAP results should not be viewed in isolation or as a substitute for GAAP results, as excluded items may have a material impact on net income and cash flows.
Investor Verification Checklist
- Verify the specific numerical values for Q1 2007 revenue, operating income, and EPS in the referenced press release (Exhibit 99.1), as they are not included in this 8-K text.
- Confirm the exact dollar amount of the in-process R&D charge related to the TriPath Imaging acquisition.
- Review the reconciliation between GAAP and non-GAAP figures to understand the magnitude of the insurance settlement impacts on 2006 results.
- Assess the impact of foreign exchange rate fluctuations on reported revenue growth versus constant currency growth.